1
|
de Almeida Schneider R, Barros Terraciano P, Zanon P, Quandt L, Zanini Gotardi DH, Alves Garcez TN, Santi L, Beys da Silva WO, Sereno Montenegro I, Yates J, Almeida Guimarães J, Pandolfi Passos E, Berger M. Mechanisms involved in the cytoprotective effects of Lonomia obliqua venom on human endometrial stromal cells. Toxicon 2024; 240:107630. [PMID: 38342412 DOI: 10.1016/j.toxicon.2024.107630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2023] [Revised: 12/23/2023] [Accepted: 01/24/2024] [Indexed: 02/13/2024]
Abstract
The pathophysiology of recurrent pregnancy loss (RPL) involves deficiencies in the proliferation and migration capacities of endometrial stromal cells (hESCs), which impair embryo implantation and development. Since animal venoms are rich source of bioactive molecules, we aimed to characterize the cytoprotective effects of Lonomia obliqua venom on hESCs. hESCs were isolated from endometrial biopsies and the mechanisms of L. obliqua venomous secretions on cell viability, proliferation and migration were characterized. Venom components were identified by chromatography and proteomic analyses. L. obliqua venom induced hESC proliferation, viability and migration in a dose-dependent manner, both in the presence and absence of serum. By ion-exchange chromatography, one fraction enriched in cytoprotective components and devoid of hemotoxins was obtained. Venom proteome identified at least six protein classes with potential cytoprotective properties (hemolins, lipocalins, hemocyannins, antiviral proteins, antimicrobial peptides, and protease inhibitors). L. obliqua venom protected hESCs from oxidative insult. Cytoprotection was also related to nitric oxide and PKC-ERK-activation and down-regulation of cAMP-PKA-dependent pathways that control cell proliferation. L. obliqua venom-induced hESC viability, proliferation and migration occurs mainly by protecting against oxidative damage and activating ERK. Thus, L. obliqua venom components are promising pharmacological tools to understand the underlying mechanisms of hESC deficiency in RPL.
Collapse
Affiliation(s)
- Raquel de Almeida Schneider
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Embriologia e Diferenciação Celular, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Ciências da Saúde: Ginecologia e Obstetrícia, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Paula Barros Terraciano
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Embriologia e Diferenciação Celular, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Ciências da Saúde: Ginecologia e Obstetrícia, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Pamela Zanon
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Bioquímica Farmacológica, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Ciências da Saúde: Ginecologia e Obstetrícia, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Letícia Quandt
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Bioquímica Farmacológica, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Ciências da Saúde: Ginecologia e Obstetrícia, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Debora Helena Zanini Gotardi
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Embriologia e Diferenciação Celular, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Ciências da Saúde: Ginecologia e Obstetrícia, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Tuane Nerissa Alves Garcez
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Embriologia e Diferenciação Celular, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Unidade de Experimentação Animal, Centro de Pesquisa Experimental (CPE), Hospital de Clínicas de Porto Alegre (HCPA-UFRGS), Porto Alegre, RS, Brazil
| | - Lucélia Santi
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Bioquímica Farmacológica, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Laboratório de Proteômica e Microbiologia Molecular, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Biologia Celular e Molecular, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Walter Orlando Beys da Silva
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Bioquímica Farmacológica, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Laboratório de Proteômica e Microbiologia Molecular, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Biologia Celular e Molecular, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Ivan Sereno Montenegro
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Embriologia e Diferenciação Celular, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
| | - John Yates
- Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, USA
| | - Jorge Almeida Guimarães
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Bioquímica Farmacológica, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Biologia Celular e Molecular, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Eduardo Pandolfi Passos
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Embriologia e Diferenciação Celular, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Ciências da Saúde: Ginecologia e Obstetrícia, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
| | - Markus Berger
- Grupo de Reprodução e Farmacologia Celular (REPROFARM) - Laboratório de Bioquímica Farmacológica, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Programa de Pós-Graduação em Ciências da Saúde: Ginecologia e Obstetrícia, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
| |
Collapse
|
2
|
Cavalcanti MFXB, Cabette RA, Moraes AC, Diomede F, Trubiani O, Maria DA. The Effects In Vitro of Photobiomodulation Over Fibroblasts and Extracellular Matrix. Photobiomodul Photomed Laser Surg 2024; 42:140-147. [PMID: 38393824 DOI: 10.1089/photob.2023.0123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2024] Open
Abstract
Objective: The objective of this study is to evaluate the potential effects of photobiomodulation (PBM) on cell proliferation and extracellular matrix production of human fibroblasts (FN1) cultured in 2D. Background: Patients with healing difficulties suffer injuries that take time to recover. In addition, aging can be seen in our faces daily when we look in the mirror; in both situations, collagen production is reduced. Fibroblasts act in the beginning and at the end of the inflammation phase, signaling to immune agents, and platelets, and producing collagen, coordinating repair. PBM increases cell viability, proliferation, and mRNA production. Methods: Human fibroblasts were irradiated three times after cell seed (after 24, 48, and 72 h) using a gallium-aluminum arsenideGaAlAs low-level laser (LLL). Cell viability, proliferative response, synthesis of collagen types I and III, and soluble collagen production were analyzed. The statistical significance of differences between groups was determined using unpaired one-way analysis of variance (ANOVA) p < 0.05. Results: PBM increased significantly the number of fibroblasts, and the production of collagen types I (Col I) and III (Col III), after three sessions of LLL with 2.5 J per session, every 24 h, for 3 consecutive days; total energy delivered after 72 h is 7.5 J. Conclusions: This energy density of LLL increases fibroblast proliferation and collagen production in vitro without side effects.
Collapse
Affiliation(s)
- Marcos Fernando Xisto Braga Cavalcanti
- Laboratory of Development and Innovation of Instituto Butantan, São Paulo, Brazil
- Dental Clinic of the child and the adult of Nove de Julho University, São Paulo, Brazil
| | - Roseli Alves Cabette
- Laboratory of Development and Innovation of Instituto Butantan, São Paulo, Brazil
| | | | - Francesca Diomede
- Department of Medical, Oral and Biotechnological Sciences, Università degli Studi G. d'Annunzio, Pescara-Chieti, Italy
| | - Oriana Trubiani
- Department of Medical, Oral and Biotechnological Sciences, Università degli Studi G. d'Annunzio, Pescara-Chieti, Italy
| | | |
Collapse
|
3
|
Alvarez AM, Alvarez-Flores MP, DeOcesano-Pereira C, Goldfeder MB, Chudzinski-Tavassi AM, Moreira V, Teixeira C. Losac and Lopap Recombinant Proteins from Lonomia obliqua Bristles Positively Modulate the Myoblast Proliferation Process. Front Mol Biosci 2022; 9:904737. [PMID: 35847970 PMCID: PMC9280836 DOI: 10.3389/fmolb.2022.904737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2022] [Accepted: 06/09/2022] [Indexed: 11/18/2022] Open
Abstract
The pursuit of better therapies for disorders creating deficiencies in skeletal muscle regeneration is in progress, and several biotoxins are used in skeletal muscle research. Since recombinant proteins derived from Lonomia obliqua bristles, recombinant Lonomia obliqua Stuart-factor activator (rLosac) and recombinant Lonomia obliqua prothrombin activator protease (rLopap) act as cytoprotective agents and promote cell survival, we hypothesize that both rLosac and rLopap favour the skeletal muscle regeneration process. In the present work, we investigate the ability of these recombinant proteins rLosac and rLopap to modulate the production of key mediators of the myogenic process. The expression of myogenic regulatory factors (MRFs), cell proliferation, the production of prostaglandin E2 (PGE2) and the protein expression of cyclooxygenases COX-1 and COX-2 were evaluated in C2C12 mouse myoblasts pre-treated with rLosac and rLopap. We found an increased proliferation of myoblasts, stimulated by both recombinant proteins. Moreover, these proteins modulated PGE2 release and MRFs activities. We also found an increased expression of the EP4 receptor in the proliferative phase of C2C12 cells, suggesting the involvement of this receptor in the effects of PGE2 in these cells. Moreover, the recombinant proteins inhibited the release of IL-6 and PGE2, which is induced by an inflammatory stimulus by IL-1β. This work reveals rLopap and rLosac as promising proteins to modulate processes involving tissue regeneration as occurs during skeletal muscle injury.
Collapse
Affiliation(s)
- Angela María Alvarez
- Centre of Excellence in New Target Discovery -CENTD-, Butantan Institute, São Paulo, Brazil
- Pharmacology Department, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil
| | | | | | - Mauricio Barbugiani Goldfeder
- Centre of Excellence in New Target Discovery -CENTD-, Butantan Institute, São Paulo, Brazil
- Innovation and Development Labororatory, Butantan Institute, São Paulo, Brazil
| | - Ana Marisa Chudzinski-Tavassi
- Centre of Excellence in New Target Discovery -CENTD-, Butantan Institute, São Paulo, Brazil
- Innovation and Development Labororatory, Butantan Institute, São Paulo, Brazil
| | - Vanessa Moreira
- Centre of Excellence in New Target Discovery -CENTD-, Butantan Institute, São Paulo, Brazil
- Pharmacology Department, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil
- *Correspondence: Vanessa Moreira, ; Catarina Teixeira,
| | - Catarina Teixeira
- Centre of Excellence in New Target Discovery -CENTD-, Butantan Institute, São Paulo, Brazil
- Pharmacology Laboratory, Butantan Institute, São Paulo, Brazil
- *Correspondence: Vanessa Moreira, ; Catarina Teixeira,
| |
Collapse
|
4
|
Moraes JA, Rodrigues G, Guimarães-Bastos D, Nascimento-Silva V, Svensjö E, Renovato-Martins M, Berger M, Guimarães J, Barja-Fidalgo C. Effect of Lonomia obliqua Venom on Human Neutrophils. Toxins (Basel) 2021; 13:toxins13120908. [PMID: 34941745 PMCID: PMC8707409 DOI: 10.3390/toxins13120908] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2021] [Revised: 12/15/2021] [Accepted: 12/16/2021] [Indexed: 11/24/2022] Open
Abstract
The significant incidence of deforestation in South America culminates in the contact of humans with typical forests species. Among these species, one may highlight Lonomia obliqua caterpillar, which, when touched by humans, can poison them through their bristles. Therefore, better acknowledging the mechanisms involved in envenomation caused by Lonomia obliqua caterpillar bristle extract (LOCBE) may contribute to further treatments. Recently, we demonstrated that LOCBE induces a pro-inflammatory profile in endothelial cells; thus, we decided to investigate the effects of LOCBE on human polymorphonuclear neutrophils (PMN), which are the first leukocytes that migrate to the inflammatory focus. Our results showed that treatment with LOCBE induced PMN chemotaxis together with alterations in actin cytoskeleton and focal adhesion kinase (FAK) activation, favoring migration. Concurrently, LOCBE induced PMN adhesion to matrix proteins, such as collagen IV, fibronectin, and fibrinogen. Moreover, we observed that LOCBE attenuated PMN apoptosis and increased reactive oxygen species (ROS) production together with nuclear factor kB (NF-κB) activation—a redox-sensitive transcription factor—as well as interleukin (IL)-1β and IL-8 release. We call attention to the ROS-dependent effect of LOCBE on increased cell migration once an antioxidant treatment reverted it. In summary, we report that LOCBE activates PMN, inducing pro-inflammatory responses modulated by ROS.
Collapse
Affiliation(s)
- João Alfredo Moraes
- Laboratório de Biologia RedOx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Ave. Carlos Chagas Filho 373, Prédio Novo do ICB, Sala 3 3 Andar, Rio de Janeiro 21941-902, Brazil; (D.G.-B.); (C.B.-F.)
- Correspondence:
| | - Genilson Rodrigues
- Laboratório de Farmacologia Celular e Molecular, Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20551-030, Brazil; (G.R.); (V.N.-S.)
| | - Daniel Guimarães-Bastos
- Laboratório de Biologia RedOx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Ave. Carlos Chagas Filho 373, Prédio Novo do ICB, Sala 3 3 Andar, Rio de Janeiro 21941-902, Brazil; (D.G.-B.); (C.B.-F.)
| | - Vany Nascimento-Silva
- Laboratório de Farmacologia Celular e Molecular, Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20551-030, Brazil; (G.R.); (V.N.-S.)
| | - Erik Svensjö
- Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil;
| | - Mariana Renovato-Martins
- Laborotário de Imunologia e Metabolismo, Universidade Federal Fluminense, Niterói 22410-201, Brazil;
| | - Markus Berger
- Laboratório de Bioquímica Farmacológica, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-003, Brazil; (M.B.); (J.G.)
| | - Jorge Guimarães
- Laboratório de Bioquímica Farmacológica, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-003, Brazil; (M.B.); (J.G.)
- Centro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Porto Alegre 91501-970, Brazil
| | - Christina Barja-Fidalgo
- Laboratório de Biologia RedOx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Ave. Carlos Chagas Filho 373, Prédio Novo do ICB, Sala 3 3 Andar, Rio de Janeiro 21941-902, Brazil; (D.G.-B.); (C.B.-F.)
| |
Collapse
|
5
|
Lonomia obliqua Envenoming and Innovative Research. Toxins (Basel) 2021; 13:toxins13120832. [PMID: 34941670 PMCID: PMC8706654 DOI: 10.3390/toxins13120832] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2021] [Revised: 11/08/2021] [Accepted: 11/09/2021] [Indexed: 01/21/2023] Open
Abstract
As a tribute to Butantan Institute in its 120th anniversary, this review describes some of the scientific research efforts carried out in the study of Lonomia envenoming in Brazil, a country where accidents with caterpillars reach over 42,000 individuals per year (especially in South and Southeast Brazil). Thus, the promising data regarding the studies with Lonomia’s toxins contributed to the creation of new research centers specialized in toxinology based at Butantan Institute, as well as to the production of the antilonomic serum (ALS), actions which are in line with the Butantan Institute mission “to research, develop, manufacture, and provide products and services for the health of the population”. In addition, the study of the components of the Lonomia obliqua bristle extract led to the discovery of new molecules with peculiar properties, opening a field of knowledge that could lead to the development and innovation of new drugs aimed at cell regeneration and inflammatory diseases.
Collapse
|
6
|
Oliveira DS, de Souza JG, Alvarez-Flores MP, Cunegundes PS, DeOcesano-Pereira C, Lobba AM, Gomes RN, Chudzinski-Tavassi AM. Lonomia obliqua Venom Induces NF-κB Activation and a Pro-Inflammatory Profile in THP-1-Derived Macrophage. Toxins (Basel) 2021; 13:462. [PMID: 34209394 PMCID: PMC8309978 DOI: 10.3390/toxins13070462] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2021] [Revised: 06/26/2021] [Accepted: 06/28/2021] [Indexed: 01/04/2023] Open
Abstract
Envenomation caused by contact with Lonomia obliqua bristles is characterized by pain, an intense systemic proinflammatory reaction and disturbances in the coagulation cascade that can cause severe clinical manifestations and death. However, the role of immune system components in these effects is still poorly understood. In this study, we evaluated the cytotoxic effect of L. obliqua venom on THP-1-derived macrophages and its ability to modulate inflammatory markers, as well as the cytokine and chemokine release profile. Our results show that L. obliqua venom is able to directly exert a potent pro-inflammatory reaction in macrophages, characterized by the activation of the NF-κB transcription factor pathway, the expression of CD80 and CD83, and the release of pro-inflammatory mediators such as TNF-α, IL-1β, IL-6, IL-8 and CXCL10. These results suggest that macrophages can play an important role during the orchestration of the inflammatory response present in envenomation caused by Lonomia obliqua caterpillars.
Collapse
Affiliation(s)
- Douglas Souza Oliveira
- Centre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil; (D.S.O.); (J.G.d.S.); (M.P.A.-F.); (P.S.C.); (C.D.-P.); (A.M.L.); (R.N.G.)
- Development and Innovation Department, Butantan Institute, Butantã 05503-900, SP, Brazil
- Biochemistry Department, Federal University of São Paulo, Vila Clementino 04044-020, SP, Brazil
| | - Jean Gabriel de Souza
- Centre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil; (D.S.O.); (J.G.d.S.); (M.P.A.-F.); (P.S.C.); (C.D.-P.); (A.M.L.); (R.N.G.)
| | - Miryam Paola Alvarez-Flores
- Centre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil; (D.S.O.); (J.G.d.S.); (M.P.A.-F.); (P.S.C.); (C.D.-P.); (A.M.L.); (R.N.G.)
- Development and Innovation Department, Butantan Institute, Butantã 05503-900, SP, Brazil
| | - Priscila S. Cunegundes
- Centre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil; (D.S.O.); (J.G.d.S.); (M.P.A.-F.); (P.S.C.); (C.D.-P.); (A.M.L.); (R.N.G.)
- Development and Innovation Department, Butantan Institute, Butantã 05503-900, SP, Brazil
- Biochemistry Department, Federal University of São Paulo, Vila Clementino 04044-020, SP, Brazil
| | - Carlos DeOcesano-Pereira
- Centre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil; (D.S.O.); (J.G.d.S.); (M.P.A.-F.); (P.S.C.); (C.D.-P.); (A.M.L.); (R.N.G.)
- Development and Innovation Department, Butantan Institute, Butantã 05503-900, SP, Brazil
| | - Aline Maia Lobba
- Centre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil; (D.S.O.); (J.G.d.S.); (M.P.A.-F.); (P.S.C.); (C.D.-P.); (A.M.L.); (R.N.G.)
- Development and Innovation Department, Butantan Institute, Butantã 05503-900, SP, Brazil
| | - Renata N. Gomes
- Centre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil; (D.S.O.); (J.G.d.S.); (M.P.A.-F.); (P.S.C.); (C.D.-P.); (A.M.L.); (R.N.G.)
- Development and Innovation Department, Butantan Institute, Butantã 05503-900, SP, Brazil
| | - Ana Marisa Chudzinski-Tavassi
- Centre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil; (D.S.O.); (J.G.d.S.); (M.P.A.-F.); (P.S.C.); (C.D.-P.); (A.M.L.); (R.N.G.)
- Development and Innovation Department, Butantan Institute, Butantã 05503-900, SP, Brazil
| |
Collapse
|
7
|
Alvarez-Flores MP, Hébert A, Gouelle C, Geller S, Chudzinski-Tavassi AM, Pellerin L. Neuroprotective effect of rLosac on supplement-deprived mouse cultured cortical neurons involves maintenance of monocarboxylate transporter MCT2 protein levels. J Neurochem 2018; 148:80-96. [PMID: 30347438 DOI: 10.1111/jnc.14617] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2018] [Revised: 09/02/2018] [Accepted: 10/17/2018] [Indexed: 01/08/2023]
Abstract
The recombinant Lonomia obliqua Stuart-factor activator (rLosac) is a recombinant hemolin which belongs to the immunoglobulin superfamily of cell adhesion molecules. It is capable of inducing pro-survival activity in serum-deprived human umbilical vein endothelial cells (HUVECs) and fibroblasts by increasing mitochondrial metabolism. We hypothesize that it could promote neuronal survival by acting on neuroenergetics. Our study reveals that treatment of primary mouse cortical neurons cultured in neurobasal medium lacking B27 supplement with rLosac led to an enhancement of cell viability in a time- and concentration-dependent manner. In parallel, preserved or enhanced phosphorylation of Akt, p44, and p42 MAPK, as well as mTOR was observed following treatment with rLosac. During deprivation, as assessed by western blot and qRT-PCR, protein and mRNA expression of MCT2 (the predominant neuronal monocarboxylate transporter allowing lactate use as an alternative energy substrate) decreased significantly in B27 supplement-deprived cortical neurons and was hardly detected after 24 h of deprivation. Interestingly, rLosac maintained MCT2 protein expression after 24 h of deprivation including at the cell surface without preventing mRNA loss. MCT2 knockdown reduced rLosac-enhanced cell viability, confirming its involvement in rLosac effect. Enhanced uptake of lactate was detected following rLosac treatment and might contribute to rLosac-enhanced viability during deprivation. In the presence of both lactate and rLosac, cell viability was higher than in the presence of lactate alone. Our observations suggest that rLosac promotes cell viability in stressed (B27 supplement-deprived) neurons by facilitating the use of lactate as energy substrate via the preservation of MCT2 protein expression. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.
Collapse
Affiliation(s)
- Miryam P Alvarez-Flores
- Department of Physiology, University of Lausanne, Lausanne, Switzerland.,Laboratory of Molecular Biology - Centre of Excellence in New Target Discover CENTD, Butantan Institute, São Paulo, Brazil
| | - Audrey Hébert
- Department of Physiology, University of Lausanne, Lausanne, Switzerland
| | - Cathy Gouelle
- Department of Physiology, University of Lausanne, Lausanne, Switzerland
| | - Sarah Geller
- Department of Physiology, University of Lausanne, Lausanne, Switzerland
| | - Ana M Chudzinski-Tavassi
- Laboratory of Molecular Biology - Centre of Excellence in New Target Discover CENTD, Butantan Institute, São Paulo, Brazil
| | - Luc Pellerin
- Department of Physiology, University of Lausanne, Lausanne, Switzerland.,Centre de Résonance Magnétique des Systèmes Biologiques, UMR5536 CNRS, LabEx TRAIL-IBIO, Université de Bordeaux, Bordeaux Cedex, France
| |
Collapse
|
8
|
Villas-Boas IM, Bonfá G, Tambourgi DV. Venomous caterpillars: From inoculation apparatus to venom composition and envenomation. Toxicon 2018; 153:39-52. [PMID: 30145232 DOI: 10.1016/j.toxicon.2018.08.007] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2018] [Revised: 07/27/2018] [Accepted: 08/20/2018] [Indexed: 11/16/2022]
Abstract
Envenomation by the larval or pupal stages of moths occurs when the victim presses their hairs. They penetrate the subcutaneous tissue, releasing toxins such as proteolytic enzymes, histamine and other pro-inflammatory substances. Cutaneous reactions, including severe pain, oedema and erythema are frequent local manifestations of caterpillar envenomation, but, in some cases, the reactions can evolve into vesicles, bullae, erosions, petechiae, superficial skin necrosis and ulcerations. Alternatively, some individual can develop allergic reactions, renal failure, osteochondritis, deformity and immobilization of the affected joints and intracerebral bleeding. Caterpillars produce venom to protect themselves from predators; contact with humans is accidental and deserves close attention. Their venoms have not been well studied, except for toxins from some few species. The present review brings together data on venomous caterpillars of moths, primarily addressing the available literature on diversity among the different families that cause accident in humans, the structures used in their defense, venom composition and clinical aspects of the envenomations. Understanding the molecular mechanisms of action of caterpillars' toxins may lead to the development of more adequate treatments.
Collapse
Affiliation(s)
- Isadora Maria Villas-Boas
- Immunochemistry Laboratory, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil
| | - Giuliano Bonfá
- Immunochemistry Laboratory, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil
| | - Denise V Tambourgi
- Immunochemistry Laboratory, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil.
| |
Collapse
|
9
|
Sato AC, Bosch RV, Will SEA, Alvarez-Flores MP, Goldfeder MB, Pasqualoto KFM, da Silva BAVG, de Andrade SA, Chudzinski-Tavassi AM. Exploring the in vivo wound healing effects of a recombinant hemolin from the caterpillar Lonomia obliqua. J Venom Anim Toxins Incl Trop Dis 2016; 22:36. [PMID: 28031734 PMCID: PMC5175323 DOI: 10.1186/s40409-016-0093-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2016] [Accepted: 12/05/2016] [Indexed: 01/07/2023] Open
Abstract
Background Hemolin proteins are cell adhesion molecules from lepidopterans involved in a wide range of cell interactions concerning their adhesion properties. However, hemolin’s roles in cell proliferation and wound healing are not fully elucidated. It has been recently reported that rLosac, a recombinant hemolin from the caterpillar Lonomia obliqua, presents antiapoptotic activity and is capable of improving in vitro wound healing. Therefore, this study aimed to explore rLosac’s in vivo effects using a skin wound healing model in rats. Methods Circular full-thickness wounds in the rat dorsum skin were treated either with rLosac, or with saline (control), allowing healing by keeping the wounds occluded and moist. During the wound healing, the following tissue regeneration parameters were evaluated: wound closure and collagen content. Furthermore, tissue sections were subjected to histological and immunohistochemical analyses. Results The rLosac treatment has demonstrated its capacity to improve wound healing, as reflected in findings of a larger number of activated fibroblasts, proliferation of epithelial cells, increase of collagen type 1, and decrease of inflammatory infiltrate. Conclusion The findings have indicated the rLosac protein as a very promising molecule for the development of new wound-healing formulations.
Collapse
Affiliation(s)
- Ana Claudia Sato
- Laboratory of Biochemistry and Biophysics, Butantan Institute, Av. Vital Brasil 1500, São Paulo, SP 05503-900 Brazil
| | - Rosemary Viola Bosch
- Laboratory of Biochemistry and Biophysics, Butantan Institute, Av. Vital Brasil 1500, São Paulo, SP 05503-900 Brazil
| | - Sonia Elisabete Alves Will
- Laboratory of Biochemistry and Biophysics, Butantan Institute, Av. Vital Brasil 1500, São Paulo, SP 05503-900 Brazil
| | - Miryam Paola Alvarez-Flores
- Laboratory of Biochemistry and Biophysics, Butantan Institute, Av. Vital Brasil 1500, São Paulo, SP 05503-900 Brazil
| | - Mauricio Barbugiani Goldfeder
- Laboratory of Biochemistry and Biophysics, Butantan Institute, Av. Vital Brasil 1500, São Paulo, SP 05503-900 Brazil
| | | | | | - Sonia Aparecida de Andrade
- Laboratory of Biochemistry and Biophysics, Butantan Institute, Av. Vital Brasil 1500, São Paulo, SP 05503-900 Brazil
| | - Ana Marisa Chudzinski-Tavassi
- Laboratory of Biochemistry and Biophysics, Butantan Institute, Av. Vital Brasil 1500, São Paulo, SP 05503-900 Brazil
| |
Collapse
|
10
|
Wu H, Zhong Q, Zhong R, Huang H, Xia Z, Ke Z, Zhang Z, Song J, Jia X. Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment. Int J Nanomedicine 2016; 11:6337-6352. [PMID: 27932881 PMCID: PMC5135287 DOI: 10.2147/ijn.s119839] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Oleanolic acid (OA) is a triterpenoid found in various fruits and vegetables and used in traditional Chinese medicine. OA plays a crucial role in the treatment of several cancers, but poor water solubility, low permeability, and significant efflux have limited its widespread clinical use. Vitamin E-d-α-tocopheryl polyethylene glycol succinate (vitamin E-TPGS) and Pluronic P105 were used to improve the solubility and permeability and to decrease the efflux of OA. OA-loaded mixed micelles were prepared by ethanol thin-film hydration. The physicochemical properties of the micelles, including zeta potential, morphology, particle size, solubility, drug loading, and drug entrapment efficiency were characterized. OA release from micelles was slower than that from the free drug system. OA uptake by A549 non-small-cell lung cancer (NSCLC) cells was enhanced by the micelles. A tumor model was established by injecting A549 cells into nude mice. In vivo imaging showed that OA-micelles could accumulate in the tumors of nude mice. Additionally, smaller tumor size and increased expression of pro-apoptotic proteins were observed in OA-micelle-treated mice, indicating that OA-micelles are more effective than free OA in treating cancer. In vitro experiments were performed using two NSCLC cell lines (A549 and PC-9). Cytotoxicity evaluations showed that the half-maximal inhibitory concentrations of free OA and OA-micelles were 36.8±4.8 and 20.9±3.7 μM, respectively, in A549 cells and 82.7±7.8 and 56.7±4.7 μM, respectively, in PC-9 cells. Apoptosis assays revealed that the apoptotic rate of OA-micelle-treated A549 and PC-9 cells was higher than that of cells treated with the same concentration of free OA. Wound healing and transwell assays showed that migration and invasion were significantly suppressed in OA-micelle-treated cells. Immunofluorescence and Western blot analyses confirmed that the epithelial–mesenchymal transition was reversed in OA-micelle-treated cells. Mixed micelles are a promising nano-drug delivery system for lung cancer treatment.
Collapse
Affiliation(s)
- Hao Wu
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine; Key Laboratory of New Drug Delivery System of Chinese Materia Medica, Jiangsu Province Academy of Chinese Medicine, Nanjing, Jiangsu; College of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui
| | - Qingxiang Zhong
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine; Key Laboratory of New Drug Delivery System of Chinese Materia Medica, Jiangsu Province Academy of Chinese Medicine, Nanjing, Jiangsu
| | - Rongling Zhong
- Laboratory Animal Center, Jiangsu Province Academy of Chinese Medicine, Nanjing, Jiangsu
| | - Houcai Huang
- Laboratory Animal Center, Jiangsu Province Academy of Chinese Medicine, Nanjing, Jiangsu
| | - Zhi Xia
- Laboratory Animal Center, Jiangsu Province Academy of Chinese Medicine, Nanjing, Jiangsu
| | - Zhongcheng Ke
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine; College of Chemistry and Chemical Engineering, Huangshan University, Huangshan, Anhui, People's Republic of China
| | - Zhenhai Zhang
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine
| | - Jie Song
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine; Key Laboratory of New Drug Delivery System of Chinese Materia Medica, Jiangsu Province Academy of Chinese Medicine, Nanjing, Jiangsu
| | - Xiaobin Jia
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine; Key Laboratory of New Drug Delivery System of Chinese Materia Medica, Jiangsu Province Academy of Chinese Medicine, Nanjing, Jiangsu; College of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui
| |
Collapse
|
11
|
Identification of a hemolin protein from Actias selene mediates immune response to pathogens. Int Immunopharmacol 2016; 42:74-80. [PMID: 27889557 DOI: 10.1016/j.intimp.2016.11.020] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2016] [Revised: 10/21/2016] [Accepted: 11/20/2016] [Indexed: 12/23/2022]
Abstract
Hemolins play an important role in development and innate immunity in insects. In this study, a hemolin cDNA of 1412bp in Actias selene (As-HEM) was isolated and its open reading frames (ORFs) were 420 amino acid residues. Sequence analysis indicated As-HEM was homologous to those hemolins from other insects species. The recombinant protein of As-HEM was expressed in Escherichia coli, and anti-As-HEM antibodies were prepared. Real-time quantitative PCR (RT-qPCR) and western blot results revealed that mRNA and protein levels of As-HEM were mostly detected in hemocytes and hemolymph. Immune challenge assays showed that both the mRNA and protein levels of As-HEM could be induced significantly post Beauveria bassiana, E. coli, Micrococcus luteus and nuclear polyhedrosis virus challenges. Agglutination assays revealed that recombinant As-HEM could promote the agglutination of E. coli in the presence of calcium. Our results suggested that As-HEM was involved in the innate immunity of A. selene.
Collapse
|